Your browser doesn't support javascript.
loading
New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study.
Bergqvist, Joel; Andersson, Anders; Olin, Anna-Carin; Murgia, Nicola; Schiöler, Linus; Bove, Mogens; Hellgren, Johan.
Afiliação
  • Bergqvist J; Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences.
  • Andersson A; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine.
  • Olin AC; Department of Occupational and Environmental Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Murgia N; Department of Occupational and Environmental Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Medicine, Section of Occupational Medicine, Respiratory Diseases and Toxicology, University of Perugia, Perugia, Italy.
  • Schiöler L; Department of Occupational and Environmental Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Bove M; Department of ENT and Oral Maxillofacial Surgery, NU Hospital Group, Trollhättan, Sweden.
  • Hellgren J; Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences.
Int J Chron Obstruct Pulmon Dis ; 11: 2617-2623, 2016.
Article em En | MEDLINE | ID: mdl-27799760
BACKGROUND: The aim of this population-based study was to investigate the risk of developing noninfectious rhinitis (NIR) in subjects with chronic obstructive pulmonary disease (COPD). MATERIALS AND METHODS: This is a longitudinal population-based study comprising 3,612 randomly selected subjects from Gothenburg, Sweden, aged 25-75 years. Lung function was measured at baseline with spirometry and the included subjects answered a questionnaire on respiratory symptoms. At follow-up, the subjects answered a questionnaire with a response rate of 87%. NIR was defined as symptoms of nasal obstruction, nasal secretion, and/or sneezing attacks without having a cold, during the last 5 years. COPD was defined as a spirometry ratio of forced expiratory volume in 1 second divided by forced vital capacity (FEV1/FVC) <0.7. Subjects who reported asthma and NIR at baseline were excluded from the study. The odds ratios for developing NIR (ie, new-onset NIR) in relation to age, gender, body mass index, COPD, smoking, and atopy were calculated. RESULTS: In subjects with COPD, the 5-year incidence of NIR was significantly increased (10.8% vs 7.4%, P=0.005) and was higher among subjects aged >40 years. Smoking, atopy, and occupational exposure to gas, fumes, or dust were also associated with new-onset NIR. COPD, smoking, and atopy remained individual risk factors for new-onset NIR in the logistic regression analysis. CONCLUSIONS: This longitudinal population-based study of a large cohort showed that COPD is a risk factor for developing NIR. Smoking and atopy are also risk factors for NIR. The results indicate that there is a link present between upper and lower respiratory inflammation in NIR and COPD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rinite / Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rinite / Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2016 Tipo de documento: Article